ArticleNPJ primary care respiratory medicine2018
A patient-centric analysis to identify key influences in allergic rhinitis management.
Article in NPJ primary care respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06027736 (The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis in a Malaysian Tertiary Hospital), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis in a Malaysian Tertiary Hospital: A Randomised Control Trial Protocol (AR-PRISE RCT)
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Article
- The future of allergic rhinitis management: A partnership between healthcare professionals and patients.The World Allergy Organization journal · 2024Article
- Conception and pilot testing of a self-management health application for patients with pollen-related allergic rhinitis and allergic asthma-the APOLLO app.Scientific reports · 2023Article
- The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.Exploratory research in clinical and social pharmacy · 2023Article
- EUFOREA Comment on a Misleading Allergic Rhinitis Report [Response to Letter].Patient preference and adherence · 2023Article
- Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care.Journal of asthma and allergy · 2023Review
- Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.Clinical and translational allergy · 2022Article
- Medication Adherence in a Community Population with Uncontrolled Asthma.Pharmacy (Basel, Switzerland) · 2020Article
- Qualitative Exploration of Pharmacists' Feedback Following the Implementation of an "Allergic Rhinitis Clinical Management Pathway (AR-CMaP)" in Australian Community Pharmacies.Pharmacy (Basel, Switzerland) · 2020Article
- Exploring the Asthma Network in People with Allergic Rhinitis Utilizing an Egocentric Social Network Analysis.Pulmonary therapy · 2019Article
- A qualitative investigation of the allergic rhinitis network from the perspective of the patient.NPJ primary care respiratory medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis (AR) is increasingly becoming a patient self-managed disease. Just under 70% of patients purchasing pharmacotherapy self-select their treatment with no health-care professional intervention often resulting in poor choices, leading to suboptimal management and increased burden of AR on the individual and the community. However, no decision is made without external, influencing forces. This study aims to determine the key influences driving patients' decision-making around AR management. To accomplish this aim, we utilised a social network theory framework to map the patient's AR network and identify the strength of the influences within this network. Adults who reported having AR were interviewed and completed an AR network map and AR severity and quality of life questionnaires. Forty one people with AR completed the study. The AR networks of the participants had a range of 1-11 influences (alters), with an average number of 4 and a median of 5. The larger the impact of AR on their quality of life, the greater the number of alters within their network. The three most commonly identified alters were, general practitioners, pharmacists and the participants' 'own experience'. The strength of the influence of health-care professionals (HCPs) was varied. The proportion of HCPs within the AR network increased as the impact of AR on their quality of life increased. By mapping the AR network, this study demonstrated that there are multiple influences behind patient's decisions regarding AR management but the role of the HCP cannot be dismissed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.